Intraplaque haemorrhages as the trigger of plaque vulnerability. - Wikidata - awgldk - TriplyDB

Intraplaque haemorrhages as the trigger of plaque vulnerability.

Intraplaque haemorrhages as the trigger of plaque vulnerability.

http://www.wikidata.org/entity/Q37852494

about

Polysaccharide nanosystems for future progress in cardiovascular pathologies Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?Plaque hemorrhage in carotid artery disease: pathogenesis, clinical and biomechanical considerations.Atherogenesis and iron: from epidemiology to cellular level.Quantifying effect of intraplaque hemorrhage on critical plaque wall stress in human atherosclerotic plaques using three-dimensional fluid-structure interaction models Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques.Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis.Gene expression differences between stroke-associated and asymptomatic carotid plaques.Specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits.PDGFRβ signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis.Critical mechanical conditions around neovessels in carotid atherosclerotic plaque may promote intraplaque hemorrhage.Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels Blood Pressure Is a Major Modifiable Risk Factor Implicated in Pathogenesis of Intraplaque Hemorrhage: An In Vivo Magnetic Resonance Imaging Study.Atherogenesis may involve the prooxidant and proinflammatory effects of ferryl hemoglobin In-vivo quantitative T2 mapping of carotid arteries in atherosclerotic patients: segmentation and T2 measurement of plaque components.10-years experience with the Athero-Express study.Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development.Angiogenesis in the atherosclerotic plaque.2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.Cytoprotective signaling and gene expression in endothelial cells and macrophages-lessons for atherosclerosis.Colchicine for secondary prevention of cardiovascular disease.Heme on innate immunity and inflammation.Red blood cell, hemoglobin and heme in the progression of atherosclerosis Lymphatic vessels: an emerging actor in atherosclerotic plaque development.Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability.Regulation of atherosclerotic plaque inflammation.The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues.Association between Snoring and High-Risk Carotid Plaque Features.Molecular imaging of high-risk atherosclerotic plaques: is it clinically translatable?Inflammatory processes in cardiovascular disease: a route to targeted therapies.Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis.Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody High wall shear stress and high-risk plaque: an emerging concept.Vascular biology of hydrogen sulfide.Extracellular vesicles in coronary artery disease.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

P2860

Q27025494-D400ED3D-4047-4320-88F1-17CD22E76B88 Q30369217-3E67EC59-FDCA-4C63-BF17-3A945431CBBF Q30439717-170FB758-3DC9-4FAC-B7AA-268ED51CD85C Q33595279-9315A5BA-1C63-43FB-A824-37A5035E4603 Q33639926-8BFE3900-D441-447C-905F-6A55050B384E Q33902889-73516C81-7045-4A4C-A294-46191CDD527D Q35101457-4FB5816D-2D66-4F5E-BC05-669F3BCBF4CA Q35206782-D3E0FEC6-DFC5-4695-B9CB-B35BA8F15566 Q35261656-90DB6695-A7DD-4C90-879A-59ABCA973553 Q35865871-22F23D5B-3834-4079-9949-AA133F77AE5C Q36220532-0B9DC106-FA19-4D86-9EFA-463766C3D20D Q36412437-B95A5A67-734C-44A7-8601-946745F9FBE3 Q36522619-5B5A1312-6D0C-450C-9A54-593D9227E48D Q36540680-FC4D39B1-6EF4-4CBA-B477-DBE6A8E099DC Q36730591-0BA19B04-C261-4F71-93EE-AC46EA932AE1 Q36898674-9D7DBB38-9ECF-4272-9F60-710D17AE484D Q37116815-AFF2773B-C958-47E4-BC04-B21640111B3B Q37339333-14874F7B-1C53-4510-9D4E-BF02F7E9F352 Q37501981-87FDE173-FB6D-41BD-BCB2-3399FA2FC40E Q37645436-CFBFA464-AD69-4BCA-A870-83A42B42189D Q37666671-53DE48DB-A2D2-4198-998A-909614880EC3 Q37724036-0D574C23-E886-48BB-A885-FB6B90D21424 Q37998958-F09FD63D-E201-4BB0-B9A2-26F68DEF3307 Q38057357-1F8834F1-0B04-4544-B759-F6FF88E14F89 Q38178536-9E113E17-7273-4A04-AEAB-4B89A2ED4D3F Q38218093-6CE8DF1E-B7A8-4456-9C24-0935E06421B1 Q38261012-DF4D9C96-CA1B-4833-952C-012AB53230F8 Q38267259-2B716427-A85E-4EF9-A5FB-947968647A42 Q38290992-366158F0-CE0D-4D2A-8405-3B1A81926EDF Q38396097-68A29236-7882-4B76-A1C9-DBBDE946BE37 Q38585451-51B0E89F-B8C3-43B2-8663-5D36BBDBB9A1 Q38684674-277EC6EB-C3A1-403F-AA17-ACB79D8C7C4A Q38700322-490CB138-7B40-4B88-8A58-8B1C07B47EE7 Q38788685-C1FF3093-8604-43D6-A8DA-1B39AE7D4893 Q38826454-7DBE73B6-19AD-4DDE-A1AA-45CB751FA83B Q38960964-93031ECA-73B9-43F6-B689-5DFD81FEF281 Q39027912-91B56012-889A-4FD9-B88D-5DD0F634DF4B Q39113984-2AC29218-4434-4783-A6DF-2CDB14E7DBB2 Q39115035-4741BCC7-96DB-48B8-AFAB-543307FEEC88 Q39179797-EA60AC9C-7D5C-4549-A0A4-645FEAE85847

P2860

Intraplaque haemorrhages as the trigger of plaque vulnerability.

http://www.wikidata.org/entity/Q37852494

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@en

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@nl

type

label

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@en

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@nl

prefLabel

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@en

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@nl

P1433

Q37852494-D6BF3055-BEB2-4452-82C9-7979C943CE33

P1476

Q37852494-4500D7F8-F52F-4AE6-A7F9-019D8DBA2B30

P2093

Q37852494-E29F0420-9E9D-4032-AA46-36D27206FF04

Q37852494-EB02585C-C3E0-40AD-A51E-097C57094A1D

P275

Q37852494-91C5692A-CD49-4D75-AF6A-ABBB6EF9DD83

P2860

Q37852494-0099AD0C-195B-4056-932B-447F863ED6E2

Q37852494-03D76263-F897-4AB6-97B4-AC80A4BF0D68

Q37852494-05BBD602-B9C1-4DF9-9B86-C6A141E9A0DB

Q37852494-06C5FB36-D8C2-4702-BD95-E8F3C08092AA

Q37852494-07FEF065-C108-4B7F-A241-720D434640D6

Q37852494-0AF67743-E082-4B88-A285-3EB5004855F0

Q37852494-0F74CDF3-1AAD-4FF6-BF79-D72783F75E18

Q37852494-0FE6ABDB-50B3-48A2-A69D-49BF0F41F544

Q37852494-14A1BD99-1AF8-4479-8C18-E166925EB7CA

Q37852494-15EF44E6-D5C6-4436-B7B1-4CC4CD95EBD0

P304

Q37852494-CCE5253F-F4A8-404B-81DA-8F45D5F65DC2

P31

Q37852494-1726D1CD-55EA-4EBA-A0EB-376BD533D895

Q37852494-2EE789CF-9356-4E6F-866B-F02C5BA3DFDF

P356

Q37852494-A3E02725-FCB3-437D-A306-2EF77BB8EEAB

P433

Q37852494-54E53612-2E8A-405C-B855-58537CCA5569

P478

Q37852494-88CD66E6-5769-4489-AD17-6B411B632BD7

P50

Q37852494-1E7E996C-32A0-479F-87B7-5980CDB3186D

Q37852494-D8010599-7414-4C8E-9063-FA485886B86A

P5008

Q37852494-EB3AF17F-543A-4189-AAF5-30B8CB1CB0E7

P577

Q37852494-57BF2728-B007-4DC7-A3F9-D58DD57FE582

Q37852494-F288B19D-ECC2-40EC-854C-951E8AB33032

P5875

Q37852494-2B45453A-2DEA-467F-97C3-4A5CD17A5FBE

P698

Q37852494-5E7C3DCA-8DD3-45A9-98B0-E6AC6B5872BC

P921

Q37852494-9E5F2CFF-DA7D-4968-8B17-0DFCDFED3127

P932

Q37852494-B44AFE67-1C14-4032-B835-B261085210DF

P356

P1433

European Heart Journal

P1476

Intraplaque haemorrhages as the trigger of plaque vulnerability.

@en

P2093

Jean-Baptiste Michel

http://www.w3.org/2001/XMLSchema#string

Renu Virmani

http://www.w3.org/2001/XMLSchema#string

P275

P2860

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation

Atherosclerosis — An Inflammatory Disease

Concept of vulnerable/unstable plaque.

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis.

Influence of hypercholesterolemia on deformability and shape parameters of erythrocytes in hyperglycemic subjects.

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.

The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

P304

1977-85, 1985a, 1985b, 1985c

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHR054

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Eloisa Arbustini

Gerard Pasterkamp

P5008

P577

2011-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50376813

http://www.w3.org/2001/XMLSchema#string

P698

21398643

http://www.w3.org/2001/XMLSchema#string

P921

cholesterol embolism

P932

3155759

http://www.w3.org/2001/XMLSchema#string